Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome

被引:9
作者
Famula, Jessica [1 ,2 ]
Ferrer, Emilio [3 ]
Hagerman, Randi J. [1 ,4 ]
Tassone, Flora [1 ,5 ]
Schneider, Andrea [1 ,4 ]
Rivera, Susan M. [1 ,3 ,6 ]
Hessl, David [1 ,2 ]
机构
[1] Univ Calif Davis Hlth, MIND Inst, 2825 50th St, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA
[4] Univ Calif Davis, Dept Pediat, Sch Med, Sacramento, CA 95817 USA
[5] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95817 USA
[6] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95817 USA
关键词
CANTAB; Fragile X premutation; Tremor; Ataxia; Executive function; FXTAS; COGNITIVE IMPAIRMENT; EXPANDED ALLELES; RATING-SCALE; ATAXIA; MALES; FXTAS; PENETRANCE; PHENOTYPE; DIAGNOSIS; MOVEMENT;
D O I
10.1186/s11689-022-09436-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Carriers of the FMR1 premutation are at increased risk of developing a late-onset progressive neurodegenerative disease, fragile X-associated tremor/ataxia syndrome (FXTAS), characterized by intention tremor, gait ataxia, and cognitive decline. Cross-sectional studies to date have provided evidence that neuropsychological changes, such as executive function alterations, or subtle motor changes, may precede the onset of formal FXTAS, perhaps characterizing a prodromal state. However, the lack of longitudinal data has prevented the field from forming a clear picture of progression over time within individuals, and we lack consensus regarding early markers of risk and measures that may be used to track response to intervention. Methods This was a longitudinal study of 64 male FMR1 premutation carriers (Pm) without FXTAS at study entry and 30 normal controls (Nc), aged 40 to 80 years (Pm M = 60.0 years; Nc M = 57.4 years). Fifty of the Pm and 22 of the Nc were re-assessed after an average of 2.33 years, and 37 Pm and 20 Nc were re-assessed a third time after an average of another 2.15 years. Eighteen of 64 carriers (28%) converted to FXTAS during the study to date. Neuropsychological assessments at each time point, including components of the Cambridge Neuropsychological Test Automated Battery (CANTAB), tapped domains of episodic and working memory, inhibitory control, visual attention, planning, executive control of movement, and manual speed and dexterity. Age-based mixed models were used to examine group differences in change over time on the outcomes in the full sample, and differences were further evaluated in 15 trios (n = 45; 15 Pm "converters," 15 Pm "nonconverters," 15 Nc) that were one-one matched on age, education, and socioeconomic status. Results Compared to Nc, Pm showed significantly greater rates of change over time in visual working memory, motor dexterity, inhibitory control, and manual movement speed. After multiple comparison correction, significant effects remained for motor dexterity. Worsening inhibitory control and slower manual movements were related to progression in FXTAS stage, but these effects became statistically non-significant after correcting for multiple comparisons. Higher FMR1 mRNA correlated with worsening manual reaction time but did not survive multiple comparisons and no other molecular measures correlated with neuropsychological changes. Finally, trio comparisons revealed greater rate of decline in planning and manual movement speed in Pm converters compared to Pm nonconverters. Conclusions Accelerated decline in executive function and subtle motor changes, likely mediated by frontocerebellar circuits, may precede, and then track with the emergence of formal FXTAS symptoms. Further research to develop and harmonize clinical assessment of FMR1 carriers across centers is needed to prepare for future prophylactic and treatment trials for this disorder.
引用
收藏
页数:10
相关论文
共 54 条
[1]  
[Anonymous], 1997, WAIS-III manual: Wechsler adult intelligence scale-third edition
[2]   Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia [J].
Bacalman, S ;
Farzin, F ;
Bourgeois, JA ;
Cogswell, J ;
Goodlin-Jones, BL ;
Gane, LW ;
Grigsby, J ;
Leehey, MA ;
Tassone, F ;
Hagerman, RJ .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) :87-94
[3]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[4]   Selective executive markers of at-risk profiles associated with the fragile X premutation [J].
Cornish, Kim M. ;
Hocking, Darren R. ;
Moss, Simon A. ;
Kogan, Cary S. .
NEUROLOGY, 2011, 77 (07) :618-622
[5]   Lifespan changes in working memory in fragile X premutation males [J].
Cornish, Kim M. ;
Kogan, Cary S. ;
Li, Lexin ;
Turk, Jeremy ;
Jacquemont, Sebastien ;
Hagerman, Randi J. .
BRAIN AND COGNITION, 2009, 69 (03) :551-558
[6]   Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia [J].
Famula, Jessica L. ;
McKenzie, Forrest ;
McLennan, Yingratana A. ;
Grigsby, James ;
Tassone, Flora ;
Hessl, David ;
Rivera, Susan M. ;
Martinez-Cerdeno, Veronica ;
Hagerman, Randi J. .
FRONTIERS IN NEUROLOGY, 2018, 9
[7]   A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X Syndrome [J].
Filipovic-Sadic, Stela ;
Sah, Sachin ;
Chen, Liangjing ;
Krosting, Julie ;
Sekinger, Edward ;
Zhang, Wenting ;
Hagerman, Paul J. ;
Stenzel, Timothy T. ;
Hadd, Andrew G. ;
Latham, Gary J. ;
Tassone, Flora .
CLINICAL CHEMISTRY, 2010, 56 (03) :399-408
[8]   White matter disease and cognitive impairment in FMR1 premutation carriers [J].
Filley, Christopher M. ;
Brown, Mark S. ;
Onderko, Karen ;
Ray, Megan ;
Bennett, Rachael E. ;
Berry-Kravis, Elizabeth ;
Grigsby, Jim .
NEUROLOGY, 2015, 84 (21) :2146-2152
[9]   Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome [J].
Glineburg, M. Rebecca ;
Todd, Peter K. ;
Charlet-Berguerand, Nicolas ;
Sellier, Chantal .
BRAIN RESEARCH, 2018, 1693 :43-54
[10]   The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations [J].
Goetz, CG ;
Poewe, W ;
Rascol, O ;
Sampaio, C ;
Stebbins, GT ;
Fahn, S ;
Lang, AE ;
Martinez-Martin, P ;
Tilley, B ;
Van Hilten, B ;
Kleczka, C ;
Seidl, L .
MOVEMENT DISORDERS, 2003, 18 (07) :738-750